• English
  • Deutsch
  • Log In
    Password Login
    or
  • Research Outputs
  • Projects
  • Researchers
  • Institutes
  • Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Primary prevention of posttraumatic stress disorder: Drugs and implications. Review
 
  • Details
  • Full
Options
2015
Journal Article
Titel

Primary prevention of posttraumatic stress disorder: Drugs and implications. Review

Abstract
Because posttraumatic stress disorder (PTSD) is a highly debilitating condition, prevention is an important research topic. This article reviews possible prevention approaches that involve the administration of drugs before the traumatic event takes place. The considered approaches include drugs that address the sympathetic nervous system, drugs that interfere with the hypothalamic-pituitary-adrenal (HPA) axis, narcotics and other psychoactive drugs, as well as modulators of protein synthesis. Furthermore, some thoughts on potential ethical implications of the use of drugs for the primary prevention of PTDS are presented. While there are many barriers to overcome in this field of study, this paper concludes with a call for additional research, as there are currently no approaches that are well-suited for regular use.
Author(s)
Burbiel, Joachim C.
Fraunhofer-Institut für Naturwissenschaftlich-Technische Trendanalysen INT
Zeitschrift
Military medical research : MMR
Thumbnail Image
DOI
10.1186/s40779-015-0053-2
Externer Link
Externer Link
Language
English
google-scholar
Fraunhofer-Institut für Naturwissenschaftlich-Technische Trendanalysen INT
Tags
  • posttraumatic stress ...

  • PTSD

  • prevention

  • pre-treatment

  • propranolol

  • prazosin

  • ketamine

  • morphine

  • anisomycin

  • osanetant

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Send Feedback
© 2022